Clinical Trial Results TV
April 5, 2006: The Truth About ACTs
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* Case
* The Truth About Activated Clotting Time (ACT) Measurements
* Antithrombotic Strategies in PCI
* PT
* Heparin
* What Does the ACT Measure?
* ACT: Historical Perspective
* ACT Pitfalls Reference value 70 180 sec
* Precision of ACT Measurements
* ACT: Hemochron vs HemoTec

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest, John Bittl, MD, has nothing to disclose regarding this CME activity.



The Truth About ACTs

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-19-2021 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted